Guided Therapeutics, Inc. Books Investment, Signs MOU With Potential China Distributor
Guided Therapeutics of the US booked $720,000 from a group of unidentified investors and signed an MOU to negotiate China distribution rights for a cervical cancer screening device, the LuViva® Advanced Cervical Scan. The investment bought 4 million shares Guided Therapeutics stock and warrants for an additional 2 million shares. The shares are worth $560,000 at the current price.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.